Imunon CEO granted 6,615 shares in lieu of cash
Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.
Imunon, Inc. executive Stacy Lindborg, President and CEO, received an equity award of 6,615 shares of common stock on 2026-08-14. The shares were valued at $1.65 per share and were granted in lieu of cash for a portion of base salary. Following this grant, Lindborg directly holds 93,254 shares of Imunon common stock and indirectly holds an additional 778 shares through a 401(k) plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 6,615 | $1.65 | $11K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Stock granted in lieu of cash for portion of base salary
Key Figures
Key Terms
grant, award, or other acquisition financial
in lieu of cash financial
401(k) Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Imunon (IMNN) report in Stacy Lindborg's latest Form 4?
What was the size and price of the stock grant to Imunon (IMNN) CEO Stacy Lindborg?
Was the Imunon (IMNN) CEO’s new stock award a market purchase or compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.